<DOC>
	<DOCNO>NCT01344564</DOCNO>
	<brief_summary>The purpose study determine patient initiate androgen deprivation therapy ( ADT ) prostate cancer transition degarelix acetate leuprolide acetate initial three-month period without rise serum testosterone . The investigator expect testosterone quickly reliably reach castrate level initiation ADT remain castrate transition , `` testosterone surge '' leuprolide injection .</brief_summary>
	<brief_title>Initiation Androgen Deprivation Therapy Prostate Cancer Using Degarelix Followed Leuprolide</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>18 year old Histologically confirm adenocarcinoma prostate Androgen deprivation therapy indicate Baseline screen serum testosterone &lt; 150ng/dL Eastern Cooperative Oncology Group ( ECOG ) score &gt; 2 Diagnosed spinal brain metastasis Hormonal manipulation within previous 6 month</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Hormone therapy</keyword>
	<keyword>Testosterone measure</keyword>
</DOC>